H. U. Gubler

1.8k total citations · 1 hit paper
10 papers, 1.4k citations indexed

About

H. U. Gubler is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, H. U. Gubler has authored 10 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in H. U. Gubler's work include Synthesis and biological activity (3 papers), Antifungal resistance and susceptibility (2 papers) and Immunotherapy and Immune Responses (2 papers). H. U. Gubler is often cited by papers focused on Synthesis and biological activity (3 papers), Antifungal resistance and susceptibility (2 papers) and Immunotherapy and Immune Responses (2 papers). H. U. Gubler collaborates with scholars based in Japan. H. U. Gubler's co-authors include Camille Feurer, H. Stähelin, J. F. Borel, Daniel Hauser, W. Haefliger, Marco Baggiolini, Béatrice Dewald, A. Schweitzer, Kay Brune and Annemarie Closse and has published in prestigious journals such as Nature, Journal of Medicinal Chemistry and Cellular and Molecular Life Sciences.

In The Last Decade

H. U. Gubler

9 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biological effects of cyclosporin A: A new antilymphocytic agent

1976 1.1k citations J. F. Borel, Camille Feurer et al. Inflammation Research profile →

Peers

H. U. Gubler

MB

IMMUN

SURGE

TRANS

ONCOL

Camille Feurer

Michihisa Nishiyama Japan

Abbie Celniker United States

Kunio Nakahara Japan

G Mathé France

K H Stenzel United States

Hetal Patel United Kingdom

B. Goldberg United States

R. J. Perper United States

Sandrine Chouzenoux France

Camille Feurer

H. U. Gubler

640 ×1.4

MB

527 ×1.8

IMMUN

371 ×1.3

SURGE

349 ×1.3

TRANS

239 ×1.6

ONCOL

Citations per year, relative to H. U. Gubler H. U. Gubler (= 1×) peers Camille Feurer

Countries citing papers authored by H. U. Gubler

Since Specialization

Citations

This map shows the geographic impact of H. U. Gubler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. U. Gubler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. U. Gubler more than expected).

Fields of papers citing papers by H. U. Gubler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. U. Gubler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. U. Gubler. The network helps show where H. U. Gubler may publish in the future.

Co-authorship network of co-authors of H. U. Gubler

This figure shows the co-authorship network connecting the top 25 collaborators of H. U. Gubler. A scholar is included among the top collaborators of H. U. Gubler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. U. Gubler. H. U. Gubler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Borel, J. F., Camille Feurer, H. U. Gubler, & H. Stähelin. (1994). Biological effects of cyclosporin A: A new antilymphocytic agent. Inflammation Research. 43(3-4). 179–186. 73 indexed citations

2.

Bollinger, Pietro, et al.. (1990). (Benzo[4, 5]cyclohepta[l, 2‐b]thiophen‐4‐ylidene)acetic Acids: Novel Non‐ulcerogenic Antiinflammatory Agents. Helvetica Chimica Acta. 73(5). 1197–1204. 8 indexed citations

3.

Pozo, E. del, H. U. Gubler, Romain Perrelet, Todd Hager, & Karl‐Heinz Wiederhold. (1988). Non-Invasive Quantitative Estimation of Bone Density in Rats Throughout the Life Cycle and in Arthritic Osteopenia: Preliminary Results. Hormone and Metabolic Research. 20(10). 630–632. 7 indexed citations

4.

Payne, T.G., et al.. (1982). Radical scavenging and stimulation of prostaglandin synthesis not anti-inflammatory?. Nature. 296(5853). 160–162. 25 indexed citations

5.

Closse, Annemarie, W. Haefliger, Daniel Hauser, et al.. (1981). 2,3-Dihydrobenzofuran-2-ones: a new class of highly potent antiinflammatory agents. Journal of Medicinal Chemistry. 24(12). 1465–1471. 32 indexed citations

6.

Brune, Kay, H. U. Gubler, & A. Schweitzer. (1979). Autoradiographic methods for the evaluation of ulcerogenic effects of anti-inflammatory drugs. Pharmacology & Therapeutics. 5(1-3). 199–207. 17 indexed citations

7.

Gubler, H. U. & Marco Baggiolini. (1978). Pharmacological Properties of Proquazone. Scandinavian Journal of Rheumatology. 7(sup21). 8–11. 14 indexed citations

8.

Borel, J. F., Camille Feurer, H. U. Gubler, & H. Stähelin. (1976). Biological effects of cyclosporin A: A new antilymphocytic agent. Inflammation Research. 6(4). 468–475. 1126 indexed citations breakdown →

9.

Gubler, H. U., et al.. (1974). Antiinflammatory activity of the new mould metabolite 11-desacetoxy-wortmannin and of some of its derivatives. Cellular and Molecular Life Sciences. 30(2). 135–136. 57 indexed citations

10.

Gay, Martha L., et al.. (1971). [Microbiologic purity of drugs. Directions and methods for a pharmacopoeia].. PubMed. 46(6). 321–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact